|
|
|
Insider
Information: |
Manion Douglas J. |
Relationship: |
Pres and CEO, Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
41,813 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$42,231 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
41,813 |
|
|
Total
Value |
$42,231 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Arena Pharmaceuticals Inc |
ARNA |
EVP Research & Develop... |
2022-03-11 |
0 |
2021-08-15 |
0 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
Pres and CEO, Director |
2024-01-01 |
41,813 |
2023-03-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACRS |
Aclaris Therapeutics, Inc... |
Pres and CEO |
|
2023-08-01 |
4 |
D |
$9.81 |
$43,527 |
D/D |
(4,437) |
23,938 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
Pres and CEO |
|
2023-03-17 |
4 |
B |
$7.86 |
$49,532 |
D/D |
6,300 |
12,800 |
2.81 |
% |
|
ACRS |
Aclaris Therapeutics, Inc... |
Pres and CEO |
|
2023-03-09 |
4 |
B |
$7.74 |
$50,278 |
D/D |
6,500 |
6,500 |
2.81 |
% |
|
ACRS |
Aclaris Therapeutics, Inc... |
Pres and CEO |
|
2024-01-01 |
4 |
D |
$1.05 |
$9,581 |
D/D |
(9,125) |
41,813 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP Research & Development |
|
2021-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
Pres and CEO |
|
2023-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,575 |
28,375 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP Research & Development |
|
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
21,462 |
36,462 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
Pres and CEO |
|
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,000 |
50,938 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
EVP Research & Development |
|
2022-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(36,462) |
0 |
0 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|